News - CellMosaic

Two-Dose Vaccine Against Heroin and Fentanyl: A Breakthrough in Opioid Addiction Treatment

Posted by Kathryn Rodriguez on 15th Apr 2025

Congratulations to the Research Teams We applaud the collaborative work of researchers from the University of New Mexico (UNM), Duke Univers

Posted by Kathryn Rodriguez on 23rd Mar 2025

At CellMosaic®, we are committed to advancing scientific research by providing innovative bioconjugates that empower scientists to drive

Posted by Kathryn Rodriguez on 8th Mar 2025

At CellMosaic®, we’re committed to empowering researchers with high-quality, innovative, and advanced bioconjugates—making c

Posted by Kathryn Rodriguez on 6th Mar 2025

CellMosaic is proud to introduce three new maleimide-activated protein carrier products for immunization and diagnostic applications. Design

Posted by Yumei Huang CEO & Director on 27th Jan 2025

Partnership Spotlight: The Urgent Need for Opioid Treatment Every 7 minutes, someone in America loses their life to an opioid overdose. Whi

Posted by Yumei Huang on 23rd Jan 2025

Exciting news! The USPTO has just granted our latest patent for branched high-loading AqueaTether® linker technologies. This technology ca